Leaflet LIVIAL 2.5mg tablets


Indicated for: menopausal symptoms

Route of administration: oral

Substance: tibolone (hormone)

ATC: G03CX01 (Genito urinary system and sex hormones | Estrogens | Other estrogens)

Tibolone is a medication used for the treatment of menopausal symptoms such as hot flashes, night sweats, and vaginal dryness. It is also used for the prevention of osteoporosis in postmenopausal women. It acts as a synthetic steroid with estrogenic, progestogenic, and androgenic activity.

The medication is taken orally, usually once daily, as directed by a doctor. It is important for patients to follow the prescribed dosage and inform their doctor of any pre-existing conditions.

Patients should be monitored for potential side effects, such as headaches, nausea, or mood changes. Regular medical check-ups are important during treatment.

Common side effects include headaches, nausea, abdominal pain, and breast tenderness. In rare cases, severe reactions such as deep vein thrombosis or strokes may occur. Patients should be informed of these risks before starting treatment.

General data about LIVIAL 2.5mg

  • Substance: tibolone
  • Date of last drug list: 01-05-2026
  • Commercial code: W63437001
  • Concentration: 2.5mg
  • Pharmaceutical form: tablets
  • Quantity: 28
  • Product type: original
  • Price: 54.46 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: N.V. ORGANON - OLANDA
  • Holder: MERCK SHARP & DOHME ROMANIA S.R.L. - ROMANIA
  • Number: 2157/2009/01
  • Shelf life: 2 years

Compensation lists for LIVIAL 2.5mg Merck Sharp & Dohme

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

54.46 RON

27.23 RON

27.23 RON

NHP 7 (C2) - Endocrine diseases

Price

Copayment

Patient

54.46 RON

54.46 RON

0.00 RON